Patient Guide: Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05083364
Status: ACTIVE_NOT_RECRUITING
Condition: Glomerulonephritis, IGA
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Camperdown, New South Wales
  • • Concord, New South Wales
  • • Clayton, Victoria
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease - Join Clinical Trial NCTNCT05083364

How to Join This Clinical Trial - NCTNCT05083364

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Glomerulonephritis, IGA. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Glomerulonephritis, IGA. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Glomerulonephritis, IGA
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05083364 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Camperdown, New South Wales 2050 - Australia

Status: Contact for availability

Clinical Research Site

Concord, New South Wales 2139 - Australia

Status: Contact for availability

Clinical Research Site

Clayton, Victoria 3168 - Australia

Status: Contact for availability

Clinical Research Site

Tbilisi, 0112 - Georgia

Status: Contact for availability

Clinical Research Site

Cologne, 50937 - Germany

Status: Contact for availability

Clinical Research Site

Erlangen, 91054 - Germany

Status: Contact for availability

Clinical Research Site

Gamcheon, Busan 49267 - Korea, Republic of

Status: Contact for availability

Clinical Research Site

Haeundae, Busan 48108 - Korea, Republic of

Status: Contact for availability

Clinical Research Site

Goyang-si, Gyeonggi-do 10444 - Korea, Republic of

Status: Contact for availability

Clinical Research Site

Daegu, 42601 - Korea, Republic of

Status: Contact for availability

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Glomerulonephritis, IGA:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships